Design Therapeutics | 4:持股變動聲明-董事 George Simeon
Design Therapeutics | 4:持股變動聲明-董事 Prasad Deepa
Design Therapeutics | 4:持股變動聲明-董事 William Arsani
Design Therapeutics | 4:持股變動聲明-董事 LAPPE RODNEY W
Design Therapeutics | 4:持股變動聲明-董事 Schmid John P.
Design Therapeutics | 4:持股變動聲明-董事 Berger Heather A.
Design Therapeutics | 8-K:重大事件
Design Therapeutics | 10-Q:季度報表
Design Therapeutics | 8-K:Design Therapeutics公佈2024年第一季度財務業績並重點介紹即將到來的項目里程碑
Design Therapeutics | ARS:年度報告
Design Therapeutics | DEFA14A:其他
Design Therapeutics | DEF 14A:股東委託書決議
Design Therapeutics | 4:持股變動聲明-董事 Schmid John P.
Design Therapeutics | 4:持股變動聲明-董事 Berger Heather A.
Design Therapeutics | 3:首次持股聲明-高管 Kim Jae B.
Design Therapeutics | S-8:員工福利計劃證券登記
Design Therapeutics | 10-K:年度報表
Design Therapeutics | 8-K:Design Therapeutics概述了GeneTac平台的進展並公佈了2023年第四季度和全年財務業績
Design Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Kenneth Griffin(3.3%),Citadel Advisors LLC(3.2%)等
Design Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
暫無數據